CoreValve Advance-II Study: Prospective International Post-market Study

NCT01624870 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2018-09-19

Study results available
· View outcomes & findings →

Summary

The CoreValve ADVANCE-II Study is a best practices investigation of patients implanted with the Medtronic CoreValve bioprosthesis.

Conditions

  • Aortic Valve Stenosis
  • Valvular Heart Disease

Sponsors & Collaborators

  • Medtronic Cardiac Rhythm and Heart Failure

    lead INDUSTRY

Principal Investigators

  • Anna Sonia Petronio, M.D. · Azienda Ospedaliero, Universitaria Pisana

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2013-10-31
Completion
2014-03-31

Countries

  • Belgium
  • Czechia
  • Germany
  • Italy
  • Netherlands
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01624870 on ClinicalTrials.gov